APOGEPHA Arzneimittel GmbH secures contract for Pharmaceutical products - Announcement of orders awarded in accordance with Section 130 a Paragraph 8 SGB V for the preparation with the active ingredient Efbemalenograstim alfa (Ryzneuta)

Posted On: 2026-08-04

Germany, Aug. 4 -- Germany based APOGEPHA Arzneimittel GmbH has secured contract from Vergabekammer des Bundes beim Bundeskartellamt for Pharmaceutical products - Announcement of orders awarded in accordance with Section 130 a Paragraph 8 SGB V for the preparation with the active ingredient Efbemalenograstim alfa (Ryzneuta) . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

APOGEPHA Arzneimittel GmbH secures contract for Pharmaceutical products - Announcement of orders awarded in accordance with Section 130 a Paragraph 8 SGB V for the preparation with the active ingredient Efbemalenograstim alfa (Ryzneuta)